| Literature DB >> 32650477 |
Svetlana A Amitina1, Elena V Zaytseva1, Natalya A Dmitrieva2, Alyona V Lomanovich1, Natalya V Kandalintseva2, Yury A Ten1, Ilya A Artamonov1, Alexander F Markov2, Dmitrii G Mazhukin1.
Abstract
Cyclic nitrones of the imidazole series, containing a sterically hindered phenol group, are promising objects for studying antioxidant activity; on the other hand, they can form persistent hybrid phenoxyl-nitroxyl radicals (HPNs) upon oxidation. Here, a series of 5-aryl-4,4-dimethyl-4H-imidazole 3-oxides was obtained by condensation of aromatic 2-hydroxylaminoketones with 4-formyl-2,6-dialkylphenols followed by oxidation of the initially formed N-hydroxy derivatives. It was shown that the antioxidant activity of both 1-hydroxy-2,5-dihydroimidazoles and 4H-imidazole 3-oxides increases with a decrease in steric volume of the alkyl substituent in the phenol group, while the stability of the corresponding HPNs generated from 4H-imidazole 3-oxides reveals the opposite tendency.Entities:
Keywords: 4H-imidazole 3-oxides; antioxidants; cyclic hydroxylamines; electron paramagnetic resonance; hybrid phenoxyl–nitroxides; sterically hindered phenols
Mesh:
Substances:
Year: 2020 PMID: 32650477 PMCID: PMC7396990 DOI: 10.3390/molecules25143118
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Scheme 1Chemical structures of nitrones with a lateral or exocyclic C=N+O− group.
Scheme 2Examples of cyclic nitrones with an endocyclic C=N+O− group.
Scheme 3Examples of spin traps, antioxidants, and neuroprotectors containing α,α′-dialkyl–substituted phenolic or nitrone groups.
Scheme 4Synthesis of initial 4-formylphenols 23.
Scheme 5Synthesis of key compounds: 2,4-diaryl-1-hydroxy-2,5-dihydroimidazoles 20, 2,5-diaryl-4H-imidazole 3-oxides 21, and HPNs 22. Reagents and conditions: (i) R3 = OH: (Z)-PhCH=NOH, EtONa (2 equiv), EtOHabs, 0 °C → 20 °C, 72 h, 65%; (ii) R3 = H, F, Br: NH2OH⋅HCl (5 equiv), MeONa (4 equiv), MeOH, rt→Δ (6–8 h), 60–85%; (iii) R3 = OH: NH2OH⋅HCl, EtOH, rt, 48 h, then 25% aq NH3, 80%; (iv) R3 = H, F, Br: HClconc, Δ, 25–50 min, 75–85%; (v) R3 = H, F, Br, OH: NH4OAc (6–10 equiv), 4-formylphenol 23, MeOH (or EtOHabs), rt, 6–12 h, then 0 °C, 12 h, 68–98%; (vi) R3 = H, F, Br, OH: Cu(OAc)2⋅H2O (20 mol%), 16% aq NH3, O2, MeOH, rt, 1–6 h, 81–100%; (vii) R3 = H, F, Br: CHCl3, PbO2, 296 K, 1 min, then dilution with PhMe, argon, 75–85% for 22e,j,o.
The library of new compounds prepared in this study.
| Compound (s) | R3 | R1 | R2 | Yield of 20, % | Yield of 21, % |
|---|---|---|---|---|---|
| Number (s) | |||||
|
| H | Me | Me | 87 | 87 |
|
| H | Me | Cy * | 87 | 81 |
|
| H | 75 | 87 | ||
|
| H | Cy | Cy | 91 | 93 |
|
| H | 78 | 97 | ||
|
| F | Me | Me | 87 | 86 |
|
| F | Me | Cy | 91 | 86 |
|
| F | 85 | 96 | ||
|
| F | Cy | Cy | 82 | 96 |
|
| F | 76 | 90 | ||
|
| Br | Me | Me | 98 | 91 |
|
| Br | Me | Cy | 93 | 94 |
|
| Br | 78 | 97 | ||
|
| Br | Cy | Cy | 89 | 100 |
|
| Br | 88 | 93 | ||
|
| OH | Me | Me | 68 | 83 |
|
| OH | 70 | 90 | ||
|
| OH | Cy | Cy | 73 | 85 |
|
| OH | 76 | 82 |
* Cy = Cyclohexyl (C6H11).
Quantitative ARA characteristics of imidazole derivatives 20 and 21 in initiated cumene oxidation (60 °C) *.
| Compound | R3 | R1 | R2 |
| |
|---|---|---|---|---|---|
|
| H | Me | Me | 3.9 ± 0.3 | 5.1 ± 0.8 |
|
| H | Me | Cy | 4.5 ± 0.5 | 5.0 ± 1.2 |
|
| H | 4.0 ± 0.1 | 4.5 ± 0.1 | ||
|
| H | Cy | Cy | 4.4 ± 0.1 | 5.0 ± 0.8 |
|
| H | 3.2 ± 0.3 | 4.0 ± 0.3 | ||
|
| F | Me | Me | 4.1 ± 0.1 | 4.9 ± 0.4 |
|
| F | Me | Cy | 4.7 ± 0.2 | 5.6 ± 0.6 |
|
| F | 4.5 ± 0.1 | 4.5 ± 0.3 | ||
|
| F | 2.8 ± 0.3 | 4.7 ± 0.8 | ||
|
| Br | Me | Me | 4.44 ± 0.02 | 6.4 ± 0.1 |
|
| Br | Me | Cy | 4.83 ± 0.02 | 4.1 ± 0.5 |
|
| Br | 4.5 ± 0.1 | 3.7 ± 0.1 | ||
|
| Br | Cy | Cy | 4.7 ± 0.2 | 5.1 ± 0.9 |
|
| Br | 3.2 ± 0.2 | 4.0 ± 0.2 | ||
|
| H | Me | Me | 2.1 ± 0.1 | 6.0 ± 0.6 |
|
| H | Me | Cy | 2.05 ± 0.02 | 6.0 ± 0.6 |
|
| H | 2.1 ± 0.1 | 5.1 ± 0.5 | ||
|
| H | 1.9 ± 0.2 | 4.1 ± 0.7 | ||
|
| F | Me | Me | 2.11 ± 0.04 | 4.9±0.2 |
|
| F | Me | Cy | 2.1 ± 0.1 | 6.6 ± 0.9 |
|
| F | 2.1 ± 0.1 | 5.5 ± 0.7 | ||
|
| F | 1.9 ± 0.2 | 3.9 ± 0.3 | ||
|
| Br | Me | Me | 2.4 ± 0.1 | 5.5 ± 0.4 |
|
| Br | Me | CyH | 2.3 ± 0.1 | 5.2 ± 0.4 |
|
| Br | 2.34 ± 0.04 | 4.3 ± 0.4 | ||
|
| Br | Cy | Cy | 2.5 ± 0.1 | 5.9 ± 0.9 |
|
| Br | 2.0 ± 0.2 | 3.8 ± 0.1 |
* For comparison, the k constant for 3,5-dibutyl-4-hydroxytoluene (BHT) in this model system is 3.1 × 104 M−1•s−1.
Scheme 6Possible oxidative transformations of 1-hydroxy-2,5-dihydroimidazoles under the action of peroxide radicals as exemplified by diisopropyl substituted derivative 20h. Colored circles indicate the sites where the predominant attack of the peroxide radical occurs.
Figure 1Chemical structures of HPNs 22a–o.
Figure 2EPR spectra recorded for diluted and oxygen-free toluene solutions of HPNs at 295 K: (a) 22a, (b) 22b, (c) 22c, and (d) 22d. Black curve: experimental spectra; red curve: simulated spectra with the parameters listed in Table 3.
Figure 3EPR spectra acquired for diluted and oxygen-free toluene solutions of HPNs at 295 K: (a) 22e, (b) 22j, and (c) 22o.
EPR parameters used for 22a–o spectral simulations. [R2h]/[Ro]: a relative proportion of HPNs that survived after keeping the solution of the radical for 2 h in an argon atmosphere.
| HPNs | giso | AN1, mT | AN3, mT | AH2, mT | AH6, mT | AH(Me), mT | AH(Cy), mT | AH(i-Pr), mT | AF, mT | [R2h]/[Ro] |
|---|---|---|---|---|---|---|---|---|---|---|
|
| 2.0049 | 0.343 | 0.045 | 0.216 | 0.100 | 0.767 | - | - | - | 0.85 |
| 0.612 | ||||||||||
|
| 2.0059 | 0.437 | 0.042 | 0.150 | 0.132 | 0.534 | 0.256 | - | - | 0.46 |
|
| 2.0063 | 0.539 | 0.066 | 0.265 | 0.265 | - | - | 0.150 | - | 0.77 |
| 0.150 | ||||||||||
|
| 2.0063 | 0.536 | 0.062 | 0.247 | 0.247 | - | 0.163 | - | - | 0.75 |
| 0.163 | ||||||||||
|
| 2.0059 | 0.550 | 0.062 | 0.163 | 0.155 | - | - | - | - | 1 |
|
| 2.0049 | 0.377 | 0.051 | 0.312 | 0.100 | 0.775 | - | - | - | 0.83 |
| 0.620 | ||||||||||
|
| 2.0059 | 0.439 | 0.042 | 0.160 | 0.130 | 0.529 | 0.258 | 0.51 | ||
|
| 2.0063 | 0.541 | 0.064 | 0.267 | 0.267 | - | - | 0.155 | - | 0.81 |
| 0.155 | ||||||||||
|
| 2.0063 | 0.539 | 0.060 | 0.249 | 0.249 | - | 0.161 | - | - | 0.79 |
| 0.161 | ||||||||||
|
| 2.0059 | 0.552 | 0.061 | 0.166 | 0.152 | - | - | - | 0.043 | 1 |
|
| 2.0049 | 0.358 | 0.049 | 0.225 | 0.066 | 0.747 | - | - | - | 0.81 |
| 0.656 | ||||||||||
|
| 2.0059 | 0.439 | 0.042 | 0.155 | 0.133 | 0.529 | 0.260 | - | - | 0.43 |
|
| 2.0064 | 0.538 | 0.065 | 0.263 | 0.263 | - | - | 0.156 | - | 0.67 |
| 0.156 | ||||||||||
|
| 2.0063 | 0.541 | 0.071 | 0.258 | 0.258 | - | 0.162 | - | - | 0.68 |
| 0.162 | ||||||||||
|
| 2.0059 | 0.548 | 0.063 | 0.163 | 0.158 | - | - | - | - | 1 |
EPR parameters for HPNs 22a–o calculated at the UB3LYP/6-31G(d) level of theory; the solvent effect was taken into account via the CPCM-model (solvent: toluene).
| HPN | AN1, mT | AN3, mT | AH2, mT | AH6, mT | AH(Me), mT | AH(Cy), mT | AH(i-Pr), mT | AF, mT |
|---|---|---|---|---|---|---|---|---|
|
| 0.526 | 0.110 | 0.249 | 0.232 | 0.425 | - | - | - |
| 0.462 | ||||||||
|
| 0.523 | 0.110 | 0.231 | 0.247 | 0.459 | 0.243 | - | - |
|
| 0.519 | 0.110 | 0.233 | 0.250 | - | - | 0.125 | - |
| 0.134 | ||||||||
|
| 0.522 | 0.110 | 0.231 | 0.247 | - | 0.179 | - | - |
| 0.194 | ||||||||
|
| 0.525 | 0.109 | 0.228 | 0.246 | - | - | - | - |
|
| 0.526 | 0.110 | 0.228 | 0.246 | - | - | - | −0.122 |
|
| 0.522 | 0.113 | 0.232 | 0.249 | - | - | - | - |
Figure 4Mulliken atomic spin populations for (a)22e, (b)22j, (c)22o calculated at the UB3LYP/6-31G(d) level of theory.
Figure 5A time-dependent EPR spectrum recorded for a diluted and oxygen-free solution of HPN 22a in PhMe: (a,d) immediately after radical formation; (b,e) at 1 h after radical formation; (c,f) 2 h after radical formation. The figure shows spectra that are normalized to the maximum on the y-axis (a,b) as well as non-normalized spectra (d–f).
Figure 6Kinetics of decomposition of HPNs 22c and 22d in diluted and oxygen-free toluene solutions.